Pepcid ac and Geodon drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Pepcid ac (famotidine) and Geodon (ziprasidone hydrochloride). Common drug interactions include chronic kidney disease among females and aggression among males.
The phase IV clinical study analyzes what interactions people have when they take Pepcid ac and Geodon. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.
What is Pepcid ac?
Pepcid ac has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 9,573 Pepcid ac users. Check the latest studies of Pepcid ac.
What is Geodon?
Geodon has active ingredients of ziprasidone hydrochloride. It is often used in bipolar disorder. eHealthMe is studying from 19,505 Geodon users. Check the latest studies of Geodon.
14 people who take Pepcid ac and Geodon together, and have interactions are studied.

What are the common drug interactions of Pepcid Ac and Geodon, by gender? *:
female:
- Chronic kidney disease
- Eye disorder
- Renal failure (kidney dysfunction)
- Anxiety
- Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs)
- Cerebral dysgenesis (abnormal brain development)
- Cerebral palsy
- Craniosynostosis (a baby is born with an abnormally shaped skull or develops one during growth)
- Developmental delay
- Jaundice neonatal (yellowing of skin in neonate)
male:
- Aggression
- Agitation (state of anxiety or nervous excitement)
- Thrombocytopenia (decrease of platelets in blood)
- Type 2 diabetes mellitus
- Unevaluable reaction
- Anaemia (lack of blood)
- Dehydration (dryness resulting from the removal of water)
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Electrolyte imbalance
- Hallucination (an experience involving the perception of something not present)
What are the common drug interactions of Pepcid Ac and Geodon, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
- Cholecystitis chronic (long lasting infection of gallbladder)
- Gallbladder disorder
- Injury
- Pain
30-39:
n/a
40-49:
- Chronic kidney disease
- Abdominal distension
- Abdominal pain upper
- Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
- Asthenia (weakness)
- Back pain
- Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
- Confusional state
- Constipation
- Crying
50-59:
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Fatigue (feeling of tiredness)
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Type 2 diabetes mellitus
60+:
- Anxiety
- Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs)
- Renal failure (kidney dysfunction)
- Scoliosis (a medical condition in which a person's spine is curved from side to side)
- Talipes
- Upper respiratory tract infection
- Aggression
- Agitation (state of anxiety or nervous excitement)
- Anaemia (lack of blood)
- Death
What are the existing conditions these people have? *
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 5 people, 35.71%
- Insomnia (sleeplessness): 5 people, 35.71%
- Depression: 5 people, 35.71%
- Stress And Anxiety: 4 people, 28.57%
- Cough: 3 people, 21.43%
- High Blood Cholesterol: 3 people, 21.43%
- Hypersensitivity: 3 people, 21.43%
- Fluid Retention (an abnormal accumulation of fluid in the blood): 3 people, 21.43%
- Hypokalemia (low potassium): 3 people, 21.43%
- Immune System Disorder: 3 people, 21.43%
* Approximation only. Some reports may have incomplete information.
Do you take Pepcid ac and Geodon?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Pepcid ac and Geodon:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Pepcid ac:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Geodon:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pepcid ac and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Geodon and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on famotidine and ziprasidone hydrochloride (the active ingredients of Pepcid ac and Geodon, respectively), and Pepcid ac and Geodon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Hypoglycemia in Levothroid, how severe and when it was recovered? - 3 seconds ago
- Abdominal Tenderness and drugs of ingredients of budesonide - 5 seconds ago
- Movement - Uncontrolled Or Slow and drugs of ingredients of carboplatin - 7 seconds ago
- Drug interactions of Glyburide and Ciprofloxacin - 7 seconds ago
- Meloxicam and Taste - Impaired for Women aged 50-59 - 10 seconds ago
- Meloxicam and Loss Of Taste for Women aged 50-59 - 10 seconds ago
- Meloxicam and Dysgeusia for Women aged 50-59 - 10 seconds ago
- Meloxicam and Metallic Taste for Women aged 50-59 - 10 seconds ago
- Could Mobic cause Numbness And Tingling? - 17 seconds ago
- Could Profen cause Sinus Congestion? - 28 seconds ago